Hypermutated Tumor DNA in Blood Predicts Immunotherapy Response Hypermutated Tumor DNA in Blood Predicts Immunotherapy Response

Hypermutated circulating tumor DNA on “ liquid biopsy ” predicts responses to checkpoint inhibitor-based immunotherapy in patients with various malignancies, researchers report.Reuters Health Information
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Hematology-Oncology News Source Type: news